Cutis Laxa, Autosomal Recessive, Type IIB
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
In summary, recurrent de novo mutations, affecting the highly conserved residue Arg138 of P5CS, cause an autosomal-dominant form of cutis laxa with progeroid features.
|
26320891 |
2015 |
Progeria
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, the clinical phenotype caused by ALDH18A1 mutations is diverse, with variable degree of progeria in children, but always in association with neurologic disease.
|
24767728 |
2014 |
Retinal Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Cutis laxa, fat pads and retinopathy due to ALDH18A1 mutation and review of the literature.
|
24767728 |
2014 |
Agenesis of corpus callosum
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Corpus callosum dysgenesis was associated with PYCR1 and ALDH18A1 mutations.
|
23963297 |
2014 |
Complicated hereditary spastic paraplegia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Novel mutations in the ALDH18A1 gene in complicated hereditary spastic paraplegia with cerebellar ataxia and cognitive impairment.
|
29915212 |
2018 |
Dysgenesis of corpus callosum
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Corpus callosum dysgenesis was associated with PYCR1 and ALDH18A1 mutations.
|
23963297 |
2014 |
Congenital cutis laxa
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Severe congenital cutis laxa with cardiovascular manifestations due to homozygous deletions in ALDH18A1.
|
24913064 |
2014 |
Spastic paraplegia type 5A, recessive
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We present a 19-year old male patient with autosomal recessive spastic paraplegia and compound heterozygosity for two ALDH18A1 mutations, one in each of the P5CS domains.
|
29754261 |
2018 |
Abnormality of the skeletal system
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Autosomal dominant (AD) complex HSP with skeletal abnormalities are consistently seen only in SPG9 (spastic gait type 9).
|
30029526 |
2018 |
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism.
|
26297558 |
2016 |
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mitochondrial medicine in the omics era.
|
29903433 |
2018 |
De Barsy syndrome
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
An atlas of genetic influences on human blood metabolites.
|
24816252 |
2014 |
De Barsy syndrome
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa.
|
22829427 |
2013 |
De Barsy syndrome
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Further expansion of the phenotypic spectrum associated with mutations in ALDH18A1, encoding Δ¹-pyrroline-5-carboxylate synthase (P5CS).
|
21739576 |
2011 |
De Barsy syndrome
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mitochondrial medicine in the omics era.
|
29903433 |
2018 |
De Barsy syndrome
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism.
|
26297558 |
2016 |
De Barsy syndrome
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
De Barsy syndrome: a review of the phenotype.
|
18388779 |
2008 |
De Barsy syndrome
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Cutis laxa, fat pads and retinopathy due to ALDH18A1 mutation and review of the literature.
|
24767728 |
2014 |
De Barsy syndrome
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Severe congenital cutis laxa with cardiovascular manifestations due to homozygous deletions in ALDH18A1.
|
24913064 |
2014 |
De Barsy syndrome
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
SPASTIC PARAPLEGIA 9, AUTOSOMAL DOMINANT (disorder)
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mitochondrial medicine in the omics era.
|
29903433 |
2018 |
SPASTIC PARAPLEGIA 9, AUTOSOMAL DOMINANT (disorder)
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Recurrent De Novo Mutations Affecting Residue Arg138 of Pyrroline-5-Carboxylate Synthase Cause a Progeroid Form of Autosomal-Dominant Cutis Laxa.
|
26320891 |
2015 |
SPASTIC PARAPLEGIA 9, AUTOSOMAL DOMINANT (disorder)
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
SPASTIC PARAPLEGIA 9, AUTOSOMAL DOMINANT (disorder)
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism.
|
26297558 |
2016 |